Glucose metabolism and diabetogenic gene expression analysis of chloroform fraction of Andrographis paniculata (Nees) whole herb in diabetic albino mice

J Complement Integr Med. 2012 Aug 10:9:Article 21. doi: 10.1515/1553-3840.1632.

Abstract

Exposure of rampant higher glucose level in diabetic condition could lead earlier and late diabetic complication eventually caused malign effect in body organs. The aim of the present work was to analyze the anti-diabetic potential of chloroform fraction of ethanol extract of Andrographis paniculata (AP) and diabetes laden gene expression alteration. In streptozotocin (60 mg/kg bw, i.p.) induced Type 2 diabetes albino mice, two weeks consecutive repeated dose treatment of chloroform fraction of AP at dose of 200 mg/kg, orally was evaluated for antidiabetic screening. Fasting blood glucose, oral glucose tolerance, serum lipid profile, tissues glycogen content, glucose 6-phosphatase and hexokinase enzymes level in liver, in vitro and in vivo insulin estimation were measured on last day of treatment. Subsequently presence of responsible phytoconstituents for respective activity was observed by HPLC. In diabetic mice, the fraction reduced the level of harmful cholesterol, while increased the favorable cholesterol significantly. Biochemical enzymes like glycogen, glucose-6-phosphatase and hexokinase were evaluated in body tissues. Apart from this in vitro, in vivo insulin estimation and diabetogenic gene expression analysis like GK, PEPCK, G-6pase, Glut-4, AR, PPAR-α,γ and TNF-α were evaluated using RT-PCR technique. Antidiabetic screening of fraction of AP at molecular level revealed significant antidiabetic activity.

Publication types

  • Evaluation Study

MeSH terms

  • Administration, Oral
  • Andrographis* / chemistry
  • Animals
  • Biomarkers / metabolism
  • Blood Glucose / drug effects*
  • Blood Glucose / genetics
  • Blood Glucose / metabolism
  • Chloroform
  • Chromatography, High Pressure Liquid
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / metabolism
  • Drug Administration Schedule
  • Gene Expression Regulation / drug effects*
  • Genetic Markers
  • Glucose Tolerance Test
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Mice
  • Oligonucleotide Array Sequence Analysis
  • Phytotherapy*
  • Plant Extracts / chemistry
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Plant Leaves / chemistry
  • Plants, Medicinal / chemistry
  • Random Allocation
  • Reverse Transcriptase Polymerase Chain Reaction
  • Streptozocin
  • Treatment Outcome

Substances

  • Biomarkers
  • Blood Glucose
  • Genetic Markers
  • Hypoglycemic Agents
  • Plant Extracts
  • Streptozocin
  • Chloroform